Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xielikang Capsule is a Traditional Chinese Medicine (TCM) formulation developed by Beijing Ditan Hospital for the treatment of chronic diarrhea in patients with HIV/AIDS. It is typically utilized as a complementary therapy alongside other TCM recipes, such as the Jianpizhixie recipe, and conventional anti-diarrheal agents like loperamide. The formulation is designed to address the gastrointestinal complications associated with advanced HIV infection, which frequently manifest as persistent diarrhea. Xielikang Capsule has been evaluated in Phase 4 randomized, double-blind, controlled clinical trials in China to assess its efficacy and safety in improving clinical symptoms and quality of life for this patient population.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xielikang Capsule.